Venture Capital Calls for Looser Biotech IPO Rules in Hong Kong and China
Venture Capital Calls for Looser Biotech IPO Rules in Hong Kong and China – CPPCC member Nisa Leung says regulatory bottlenecks are slowing the biotech pipeline as foreign capital returns to the sector